A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Lactobacillus Paracasei Freeze Dried Powder | Lactobacillus paracasei (commonly abbreviated as L. paracasei) is a gram-positive, facultatively heterofermentative species of lactic acid bacteria that are commonly used in dairy product fermentation and probiotics. L. paracasei is a bacterium that operates by commensalism. It is commonly found in many human habitats such as human intestinal tracts and mouths as well as sewages, silages, and previously mentioned dairy products. Group: Probiotics. Synonyms: Lactobacillus Paracasei Freeze Dried Powder; Lactobacillus Paracasei. Activity: 10 billion CFU/g or more. Stability: 24 Months. Appearance: White To Light Yellow-Colored, Free-Flowing Powder. Storage: Recommend storage at refrigeration (4 °C) or frozen temperature (-18 °C) in original, sealed package until processed. Form: Powder. Antiallergic Formula, Oral Health Formula, Prenatal Probiotic Formula. Cat No: PRBT-021. |  |
| Lactobacillus Plantarum Freeze Dried Powder | Lactobacillus plantarum is a widespread member of the genus Lactobacillus, commonly found in many fermented food products as well as anaerobic plant matter. It is also present in saliva (from which it was first isolated). L. plantarum is Gram positive, bacilli shaped bacterium. L. plantarum cells are rods with rounded ends, straight, generally 0.9 - 1.2 μm wide and 3 - 8 μm long, occurring singly, in pairs or in short chains. L. plantarum has one of the largest genomes known among the lactic acid bacteria and is a very flexible and versatile species. It is estimated to grow between pH 3.4 and 8.8. Lactobacillus plantarum can grow in the temperature range 12 °C to 40 °C. Group: Probiotics. Synonyms: Lactobacillus Plantarum Freeze Dried Powder; Lactobacillus Plantarum. Activity: 10 billion CFU/g or more. Stability: 24 Months. Appearance: White To Light Yellow-Colored, Free-Flowing Powder. Storage: Recommend storage at refrigeration (4 °C) or frozen temperature (-18 °C) in original, sealed package until processed. Form: Powder. Anti Helicobacter Pylori Formula, Female Vaginal Health Formula, Gut Health Formula, Sleep Quality Improvement Formula, Weight Control Formula. Cat No: PRBT-022. | |
| Lactobacillus Reuteri Freeze Dried Powder | Lactobacillus reuteri is a Gram-positive bacterium that naturally inhabits the gut of mammals and birds, as well it can be also found in the natural environments like the fermented foods, meet, dairy products. It can grow in both oxygen residual or not, can grow better at the aerobic condition, even can survive in the Nitrogen Dioxide condition. Group: Probiotics. Synonyms: Lactobacillus Reuteri Freeze Dried Powder in China; Lactobacillus Reuteri. Activity: 10 billion CFU/g or more. Stability: 24 Months. Appearance: White To Light Yellow-Colored, Free-Flowing Powder. Storage: Recommend storage at refrigeration (4 °C) or frozen temperature (-18 °C) in original, sealed package until processed. Form: Powder. Antiallergic Formula, Female Vaginal Health Formula. Cat No: PRBT-023. | |
| Lactobacillus Rhamnosus 200 Billion CFU/g | Lactobacillus Rhamnosus 200 Billion CFU/g. |  CA, FL & NJ |
| Lactobacillus Rhamnosus Food Supplement | Probiotics Lactobacillus rhamnosus LRa05 is a bacteria that exists naturally inthe body, primarily in the intestines. It helps maintain a balance of 'goodbacteria' needed to prevent the growth of harmful bacteria in the stomach andintestines. It has been used to treat or prevent diarrhea caused by rotavirusand other viral illnesses in babies and children. It has also been used totreat diarrhea that can occur while taking antibiotics or while traveling toforeign countries. Lactobacillusrhamnosus is a gram positive rods of variedlengths, commonly occurring in short chains. Applications: Powder, granule, tablets, capsules. Group: Others. Synonyms: Lactobacillus Rhamnosus Food Supplement; Lactobacillus Rhamnosus. Purity: >90%. Activity: o 300 billion (3.00E+11) CFU/gm; o Overage provided. Stability: 24 Months. Appearance: White To Light Yellow-Colored, Free-Flowing Powder. Storage: Recommend storage at refrigeration (4 °C) or frozen temperature (-18 °C) in original, sealed package until processed. Lactobacillus Rhamnosus Food Supplement; Lactobacillus Rhamnosus. Cat No: PRBT-024. | |
| Lactobacillus Rhamnosus Freeze Dried Powder | Lactobacillus rhamnosus is a bacterium that originally was considered to be a subspecies of L. casei, but genetic research found it to be a species of its own. It is a short Gram-positive heterofermentative facultative anaerobic non-spore-forming rod that often appears in chains. Some strains of L. rhamnosus bacteria are being used as probiotics, and are particularly useful in treating female-related infections, most particularly very difficult to treat cases of bacterial vaginosis (or "BV"). The Lactobacillus rhamnosus and L. reuteri species are most commonly found in the healthy female genito-urinary tract and are most helpful to supplement in order to regain control over dysbiotic bacterial overgrowth during an active infection. L. rhamnosus sometimes is used in yogurt and dairy products such as fermented and unpasteurized milk and semi-hard cheese. Group: Probiotics. Synonyms: Lactobacillus Rhamnosus Food Supplement; Lactobacillus Rhamnosus. Activity: 10 billion CFU/g or more. Stability: 24 Months. Appearance: White To Light Yellow-Colored, Free-Flowing Powder. Storage: Recommend storage at refrigeration (4 °C) or frozen temperature (-18 °C) in original, sealed package until processed. Form: Powder. Antiallergic Formula, Female Vaginal Health Formula, Gut Health Formula, Sleep Quality Improvement Formula. Cat No: PRBT-024. | |
| Lactobacillus Salivarius Freeze Dried Powder | Lactobacillus salivarius is a probiotic bacteria species that has been found to live in the gastrointestinal tract and exert a range of therapeutic properties including suppression of pathogenic bacteria. Group: Probiotics. Synonyms: Lactobacillus Salivarius Freeze Dried Powder; Lactobacillus Salivarius. Activity: 10 billion CFU/g or more. Stability: 24 Months. Appearance: White To Light Yellow-Colored, Free-Flowing Powder. Storage: Recommend storage at refrigeration (4 °C) or frozen temperature (-18 °C) in original, sealed package until processed. Form: Powder. Antiallergic Formula, Oral Health Formula, Prenatal Probiotic Formula. Cat No: PRBT-025. | |
| Lactobionate hydrazide | Lactobionate hydrazide. |  |
| Lactobionic acid | Lactobionic acid. Alternative Names: 4-O-β-D-Galactopyranosyl-D-gluconic acid. CAS No. 96-82-2. Purity: 97%. Product ID: ACM96822-3. Molecular formula: C12H22O12. Mole weight: 358.3. IUPAC Name: (2R,3R,4R,5R)-2,3,5,6-Tetrahydroxy-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexanoic acid. Canonical SMILES: C(C1C(C(C(C(O1)OC(C(CO)O)C(C(C(=O)O)O)O)O)O)O)O. Alfa Chemistry - ISO 9001:32057 Certified. |  |
| Lactobionic acid | A disaccharide sugar acid derived from galactose and gluconate. Alternative Names: 4-O-b-D-Galactopyranosyl-D-gluconic acid; 4-(beta-D-Galactosido)-D-gluconic acid. Grades: 98%. CAS No. 96-82-2. Molecular formula: C12H22O12. Mole weight: 358.29. | |
| Lactobionic acid | 100g Pack Size. Group: Biochemicals, Building Blocks, Carbohydrates, Research Organics & Inorganics. Formula: C12H22O12. CAS No. 96-82-2. Prepack ID 34227073-100g. Molecular Weight 358.3. See USA prepack pricing. |  |
| Lactobionic acid | 25g Pack Size. Group: Biochemicals, Building Blocks, Carbohydrates, Research Organics & Inorganics. Formula: C12H22O12. CAS No. 96-82-2. Prepack ID 34227073-25g. Molecular Weight 358.3. See USA prepack pricing. | |
| Lactobionic Acid BP/EP/USP | Lactobionic Acid BP/EP/USP. CAS No. 96-82-2. Molecular formula: C12H22O12. |  |
| Lactobionic acid ethyl ester | Lactobionic acid ethyl ester. | |
| lactocepin | Associated with the cell envelope of Lactococcus lactis and attached via a C-terminal membrane anchor sequence. Responsible for the hydrolysis of casein in milk and the provision of peptides essential to cell growth. Important in cheese making and the production of lactic casein, being required for rapid growth to high cell densities with concomitant production of adequate levels of lactic acid. Specificity differences between lactocepins from different starter strains may be partly responsible for imparting different flavour qualities to cheese. In peptidase family S8 (subtilisin family). Group: Enzymes. Synonyms: CEP; extracellular lactococcal proteinase; lactococcal cell wall-associated proteinase; lactococcal cell envelope-associated proteinase; lactococcal proteinase; PrtP. Enzyme Commission Number: EC 3.4.21.96. CAS No. 205510-58-3. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-4188; lactocepin; EC 3.4.21.96; 205510-58-3; CEP; extracellular lactococcal proteinase; lactococcal cell wall-associated proteinase; lactococcal cell envelope-associated proteinase; lactococcal proteinase; PrtP. Cat No: EXWM-4188. | |
| Lactocin 705 | Lactocin 705 is an antibacterial peptide isolated from Lactobacillus casei CRL 705. Alternative Names: Lac705α; Gly-Met-Ser-Gly-Tyr-Ile-Gln-Gly-Ile-Pro-Asp-Phe-Leu-Lys-Gly-Tyr-Leu-His-Gly-Ile-Ser-Ala-Ala-Asn-Lys-His-Lys-Lys-Gly-Arg-Leu-Gly-Tyr. Grades: 97.2%. | |
| Lactococcin G-a | Lactococcin G-a is an antibacterial peptide isolated from Lactococcus lactis LMGT2081. Alternative Names: Gly-Thr-Trp-Asp-Asp-Ile-Gly-Gln-Gly-Ile-Gly-Arg-Val-Ala-Tyr-Trp-Val-Gly-Lys-Ala-Leu-Gly-Asn-Leu-Ser-Asp-Val-Asn-Gln-Ala-Ser-Arg-Ile-Asn-Arg-Lys-Lys-Lys-His. Grades: 98.1%. Molecular formula: C189H303N61O55. Mole weight: 4309.86. | |
| Lactococcin Q alpha | Lactococcin Q alpha is an antibacterial peptide isolated from Lactococcus lactis QU 4. It has activity against gram-positive bacteria. Alternative Names: Ser-Ile-Trp-Gly-Asp-Ile-Gly-Gln-Gly-Val-Gly-Lys-Ala-Ala-Tyr-Trp-Val-Gly-Lys-Ala-Met-Gly-Asn-Met-Ser-Asp-Val-Asn-Gln-Ala-Ser-Arg-Ile-Asn-Arg-Lys-Lys-Lys-His. Grades: 96.9%. Molecular formula: C185H297N59O53S2. Mole weight: 4259.88. | |
| Lactococcin Q beta | Lactococcin Q beta is an antibacterial peptide isolated from Lactococcus lactis QU 5. It has activity against gram-positive bacteria. Alternative Names: Lys-Lys-Trp-Gly-Trp-Leu-Ala-Trp-Val-Glu-Pro-Ala-Gly-Glu-Phe-Leu-Lys-Gly-Phe-Gly-Lys-Gly-Ala-Ile-Lys-Glu-Gly-Asn-Lys-Asp-Lys-Trp-Lys-Asn-Ile. Grades: 96.3%. Molecular formula: C192H287N49O46. Mole weight: 4017.69. | |
| Lactococcus Lactis Freeze Dried Powder | Lactococcus lactis is a Gram-positive bacterium used extensively in the production of buttermilk and cheese, but has also become famous as the first genetically modified organism to be used alive for the treatment of human disease. Applications: dietary supplements - capsules, powder, tablets. food - bars, powdered beverages. Group: Probiotics. Synonyms: Lactococcus Lactis Freeze-drying powder in Yoghurt Health Benefits; Lactococcus Lactis. Activity: 10 billion CFU/g or more. Stability: 24 Months. Appearance: White To Light Yellow-Colored, Free-Flowing Powder. Storage: Recommend storage at refrigeration (4 °C) or frozen temperature (-18 °C) in original, sealed package until processed. Form: Powder. Lactococcus Strains. Cat No: PRBT-026. | |
| Lactococcus Lactis Freeze-drying Powder | L. lactis LLa61 was isolated from yogurt. L.lactis LLa61 is of crucial importance for manufacturing dairy products, such asbuttermilk and cheeses. When L. lactis ssp. lactis is added to milk, thebacterium uses enzymes to produce energy molecules (ATP), from lactose. Thebyproduct of ATP energy production is lactic acid. L.lactis LL162 strain is a yogurt fermentation strain growing in lower temperature of 28°C, and after 8 hours fermentation, the strain can produce flavor substance and strengthen the creamy flavor of yogurt. Also, L.lactis is a nisin producer and inhibit bacteria contaminants in the yogurt. This strain is high stability as a probiotics strain in the room temperature. Group: Others. Synonyms: Lactococcus Lactis Freeze-drying powder in Yoghurt Health Benefits; Lactococcus Lactis. Purity: >90%. Stability: 24 Months. Appearance: White To Light Yellow-Colored, Free-Flowing Powder. Lactococcus Lactis Freeze-drying powder in Yoghurt Health Benefits; Lactococcus Lactis. Cat No: PRBT-026. | |
| Lactocyclicin Q | Lactocyclicin Q is an antibacterial peptide isolated from Lactococcus sp. strain QU 12. It has activity against gram-positive bacteria and gram-negative bacteria. Alternative Names: Leu-Ile-Asp-His-Leu-Gly-Ala-Pro-Arg-Trp-Ala-Val-Asp-Thr-Ile-Leu-Gly-Ala-Ile-Ala-Val-Gly-Asn-Leu-Ala-Ser-Trp-Val-Leu-Ala-Leu-Val-Pro-Gly-Pro-Gly-Trp-Ala-Val-Lys-Ala-Gly-Leu-Ala-Thr-Ala-Ala-Ala-Ile-Val-Lys-His-Gln-Gly-Lys-Ala-Ala-Ala-Ala-Ala-Trp. | |
| Lactodifucotetraose | Lactodifucotetraose is a notable bioactive compound, emerging as a promising compound in studying ailments concerning the gastrointestinal realm. Its innate potential lies in fostering the proliferation of symbiotic gut microflora and catalyzing the intricate process of digestive assimilation. By virtue of its robust prebiotic attributes, Lactodifucotetraose efficaciously propels the state of gut well-being through studying inflammatory responses and fortifying the resilience of the immune system. Alternative Names: LDFT; Difucosyl lactose; O-6-Deoxy-α-L-galactopyranosyl-(1→3)-O-[O-6-deoxy-α-L-galactopyranosyl-(1→2)-β-D-galactopyranosyl-(1→4)]-D-glucose; 2',3-Difucosyllactose; Difucosyllactose; Lacto-difucosyl-tetraose; Fuc(a1-2)Gal(b1-4)[Fuc(a1-3)]aldehydo-Glc. Grades: 95%. CAS No. 20768-11-0. Molecular formula: C24H42O19. Mole weight: 634.58. | |
| Lactofen | Lactofen is a selective post-budding herbicide, which can effectively control broad-leaved weeds in soybean, cotton, peanut, rice, corn, grape, and other crops. Alternative Names: Benzoic acid, 5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitro-, 2-ethoxy-1-methyl-2-oxoethyl ester; 2-Ethoxy-1-methyl-2-oxoethyl 5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoate; Cobra; Cobra (herbicide); Phoenix; Phoenix (herbicide); PPG 844; 5-(2-Chloro-4-(trifluoromethyl)phenoxy)-2-nitrobenzoic acid 2-ethoxy-1-methyl-2-oxoethyl ester. Grades: 95%. CAS No. 77501-63-4. Molecular formula: C19H15ClF3NO7. Mole weight: 461.78. | |
| Lactofen | Lactofen is a herbicide that targets dicotyledonous weeds and causes oxidative stress, activating the expression of chalcone synthase and chalcone reductase[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 77501-63-4. Pack Sizes: 10 mM * 1 mL in DMSO; 100 mg; 500 mg. Product ID: HY-W019880. |  |
| Lactoferricin | Lactoferricin has Antimicrobial activity. Alternative Names: Met-Phe-Lys-Cys-Arg-Arg-Trp-Gln-Trp-Arg-Met-Lys-Lys-Leu-Gly-Ala-Pro-Ser-Ile-Thr-Cys-Val-Arg-Arg-Ala-Phe. Molecular formula: C134H212N42O27S3. Mole weight: 2939.6. | |
| Lactoferricin-B | Lactoferricin-B is an antibacterial peptide isolated from Bos taurus. Alternative Names: Lactotransferrin precursor; Phe-Lys-Cys-Arg-Arg-Trp-Gln-Trp-Arg-Met-Lys-Lys-Leu-Gly-Ala-Pro-Ser-Ile-Thr-Cys-Val-Arg-Arg-Ala-Phe. Molecular formula: C141H224N46O29S3. Mole weight: 3123.8. | |
| Lactoferricin b 15 | Lactoferricin b 15 has Antimicrobial activity. Alternative Names: Pro-Met-Phe-Lys-Cys-Trp-Arg-Trp-Gln-Trp-Arg-Trp-Lys-Lys-Leu-Gly-Ala-Met. Grades: 96.8%. | |
| Lactoferricin B (4-14) (bovine) | Lactoferricin B (4-14) (bovine) is thought to be the main protecting component from bacteria at the mucosal surfaces and in colostrum and milk. The region rich in basic amino acids of bovine lactoferricin is involved in the interaction with the bacterial phospholipid membrane and plays an important role in antimicrobial activity. Alternative Names: Lactotransferrin (20-30) (bovine); H-Arg-Arg-Trp-Gln-Trp-Arg-Met-Lys-Lys-Leu-Gly-OH; BLFC (4-14); L-arginyl-L-arginyl-L-tryptophyl-L-glutaminyl-L-tryptophyl-L-arginyl-L-methionyl-L-lysyl-L-lysyl-L-leucyl-glycine; Lactoferricin, bovine; Lactoferrin (20-30) (bovine); Lactoferrin (BL-11). Grades: ≥95%. CAS No. 183476-25-7. Molecular formula: C70H113N25O13S. Mole weight: 1544.87. | |
| Lactoferrin | Lactoferrin (LF), also known as lactotransferrin (LTF), to transferrin in a multifunctional glycoprotein. Lactoferrin is a globular glycoprotein with a molecular weight of 80 kDa, in a wide variety secretion of fluid, such as milk, saliva, tears, and nose. Lactoferrin is also present in the medium term in neutrophils secreted by some of the acinar cells. Lactoferrin can be extracted or using recombinant DNA technology from the milk. Applications: Food additives and infant formula. Group: Others. Lactoferrin. Cat No: EXTC-135. | |
| Lactoferrin | Lactoferrin. Category: Natural extract. Synonyms: COLOSTRUM;LACTOSIDEROPHILIN (BOVINE);LACTOTRANSFERRIN (BOVINE);LACTOFERRIN, HUMAN;LACTOFERRIN, HUMAN MILK;LACTOFERRIN (BOVINE). CAS No. 146897-68-9. Product ID: PIPE-0358. Molecular formula: C141H224N46O29S3. Mole weight: 3123.82. Appearance: Powder. |  |
| Lactoferrin (17-41) | Lactoferrin 17-41 (Lactoferricin B), a peptide corresponding to residues 17-41 of bovine lactoferrin, has antimicrobial activity against a wide range of microorganisms, including Gram-positive and Gramnegative bacteria, viruses, protozoa, and fungi. Lactoferrin 17-41 has antitumor activities[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: Lactoferricin B; Lfcin B. CAS No. 146897-68-9. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg. Product ID: HY-P1791. | |
| Lactoferrin (17-41) | Lactoferrin (17-41) is the 17-41 fragment of Lactoferrin that exhibits anti-fungal properties in combination of other anti-fungal agents. Uses: lactoferrin is a multifunctional glycoprotein that plays a crucial role in various biological processes, including antimicrobial activity, immune modulation, and iron homeostasis. in recent years, research has shown that lactoferrin holds great potential in the field of drug discovery and development due to its diverse range of biological activities and therapeutic properties. . saliva, te. Alternative Names: Lactoferrin; Lactoferrin, from bovine milk; Lactoferricin B; Lfcin B; H-Phe-Lys-Cys(1)-Arg-Arg-Trp-Gln-Trp-Arg-Met-Lys-Lys-Leu-Gly-Ala-Pro-Ser-Ile-Thr-Cys(1)-Val-Arg-Arg-Ala-Phe-OH. CAS No. 146897-68-9. Molecular formula: C141H224N46O29S3. Mole weight: 3123.78. | |
| Lactoferrin (322-329) (human) | Lactoferrin (322-329) (human) is a highly amyloidogenic region of lactoferrin. Alternative Names: H-Asn-Ala-Gly-Asp-Val-Ala-Phe-Val-OH; L-asparagyl-L-alanyl-glycyl-L-alpha-aspartyl-L-valyl-L-alanyl-L-phenylalanyl-L-valine; (2S,5S,8S,11S,14S)-5-benzyl-14-(2-((S)-2-((S)-2,4-diamino-4-oxobutanamido)propanamido)acetamido)-2,11-diisopropyl-8-methyl-4,7,10,13-tetraoxo-3,6,9,12-tetraazahexadecane-1,16-dioic acid. Grades: ≥95%. CAS No. 496808-32-3. Molecular formula: C35H53N9O12. Mole weight: 791.86. | |
| Lactoferrin > 95% | Lactoferrin > 95%. | CA, FL & NJ |
| Lactoferrin from Bovine milk | Lactoferrin from Bovine milk is a substance released by neutrophils. Lactoferrin from Bovine milk is an orally active multifunctional iron binding glycoprotein. Lactoferrin from Bovine milk prevents cell adhesion, growth and spreading of cell colonies. Lactoferrin from Bovine milk also has antiviral activity and inhibits microbial and viral adhesion and entry into host cells. Besides, Lactoferrin from Bovine milk has anti-inflammatory, immunomodulatory, and anti-cancer activities[1][2][3]. Uses: Scientific research. Category: Signaling pathways. CAS No. 936541-36-5. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-P3161. | |
| Lactoferrin from Bovine milk | Lactoferrin from Bovine milk. CAS No. 936541-36-5. | |
| Lactojasmone | Lactojasmone. CAS No. 7011-83-8. FEMA No. 3786. VIGON Item # 502514. Categories: Speciality Ingrdients Suppliers, Fragrances, Perfumers. |  America & Internationally |
| Lactonamycin | It is produced by the strain of Streptomyces rishiriensis MJ 773-88K4. It had strong activity against gram-positive bacteria including staphylococcus, streptococcus, enterococcus, MRSA (MIC is 0.39-0.78 μg/mL) and VRE (MIC is 0.39-0.78 μg/mL). It also has inhibitory effect on L-1210, P388, S180, FS-3, Ehrlich, B16-BL5 and other tumor cell lines (IC50 is 0.06-3.3 μg/mL). Alternative Names: (3aS,5aS,14aR)-9,13-dihydroxy-5a-{[(2S,5S,6S)-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-3a-methoxy-11-methyl-3,3a,11,12-tetrahydro-2H,5H-furo[2'',3'':4',5']furo[3',4':6,7]naphtho[2,3-e]isoindole-2,6,10,14(5aH)-tetrone; (+)-Lactonamycin. CAS No. 182234-02-2. Molecular formula: C28H27NO12. Mole weight: 569.51. | |
| Lactonamycin Z | It is produced by the strain of Streptomyces sp. AK 623. It's an antitumor antibiotic. It has weak anti-gram-positive bacterial activity. It can inhibit human tumor cells HMO2, MCF7 and Hep G2 with GI50 (μg/mL) of 1.9, 0.85 and 5.11, respectively. Molecular formula: C28H27NO13. Mole weight: 585.51. | |
| Lacto-N-biose | It is the receptor of helicobacter pylori α1,2-Focusyltransferase enzyme. Alternative Names: Galβ1-3GlcNAc; Gal-b-1,3-GlcNAc; 2-Acetamido-2-deoxy-3-O-(b-D-galactopyranosyl)-D-glucopyranose; beta-D-galactsyl-(1->3)-N-acetyl-D-glucosamine; beta-D-Galactopyranosyl-(1->3)-N-acetyl-D-glucosamine; O-β-D-Galactopyranosyl-(1-3)-N-acetylglucosamine; Lewis C. Grades: ≥95%. CAS No. 50787-09-2. Molecular formula: C14H25NO11. Mole weight: 383.35. | |
| lacto-N-biosidase | The enzyme from Streptomyces specifically hydrolyses the terminal lacto-N-biosyl residue (β-D-Gal-(1?3)-D-GlcNAc) from the non-reducing end of oligosaccharides with the structure β-D-Gal-(1?3)-β-D-GlcNAc-(1?3)-β-D-Gal-(1?R). Lacto-N-hexaose (β-D-Gal-(1?3)-β-D-GlcNAc-(1?3)-β-D-Gal-(1?3)-β-D-GlcNAc-(1?3)-β-D-Gal-(1?4)-D-Glc) is hydrolysed to form first lacto-N-tetraose plus lacto-N-biose, with the subsequent formation of lactose. Oligosaccharides in which the non-reducing terminal Gal or the penultimate GlcNAc are replaced by fucose or sialic acid are not substrates. Asialo GM1 tetraose (β-D-Gal-(1?3)-β-D-GalNAc-(1?3)-β-D-Gal-(1?4)-D-Glc) is hydrolysed very slowly, but lacto-N-neotetraose (β-D-Gal-(1?4)-β-D-GalNAc-(1?3)-β-D-Gal-(1?4)-D-Glc) is not a substrate. Group: Enzymes. Enzyme Commission Number: EC 3.2.1.140. CAS No. 146359-52-6. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-3823; lacto-N-biosidase; EC 3.2.1.140; 146359-52-6. Cat No: EXWM-3823. | |
| Lacto-N-Biosidase, Recombinant | Lacto-N-Biosidase may be used during glycoprotein analysis to better study the structure and function of glycoprotein and glycolipid sugar chains. This product can be used for specific oligosaccharide hydrolysis of type-I chain oligosaccharides, producing lacto-N-biose (Gal β 1-3 GlcNAc) as a byproduct, but not oligosaccharide hydrolysis of type-II chain oligosaccharides. As a result, Lacto-N-Biosidase can be used to distinguish type-I versus type-II glycoprotein as well as glycolipid sugar chains. When used in conjunction with α -1,3/4-Fucosidase, Lacto-N-Biosidase can also help distinguish Sialyl-Lewis x and Sialyl-Lewis a structures. Applications: Specific hydrolysis of oligosaccharides with type-i sugar chains and production of byproduct lacto-n-biose (gal β 1-3 glcnac). Group: Enzymes. Synonyms: Oligosaccharide lacto-N-biosylhydrolase; Lacto-N-Biosidase. Lacto-N-Biosidase. Mole weight: 60 kDa (SDS-PAGE). Form: Solution in 50 mM sodium acetate buffer, pH 5.5, containing 0.05% Brij-58. Source: Streptomyces sp. 142. Oligosaccharide lacto-N-biosylhydrolase; Lacto-N-Biosidase. Cat No: NATE-0855. | |
| Lacto-N-difucohexaose I | Lacto-N-difucohexaose I is an indispensable compound in the biomedical field, exhibiting remarkable immunomodulatory attributes. Its application predominantly encompasses the research of multifarious ailments, encompassing particular cancer types and autoimmune afflictions. As a propitious research, this product adeptly modulates the immune response, potentially augmenting patient outcomes with unprecedented efficacy. Alternative Names: LNDFH I; Lewisb antigen; 6-Deoxy-α-L-galactopyranosyl-(1->4)-[6-deoxy-α-L-galactopyranosyl-(1->2)-β-D-galactopyranosyl-(1->3)]-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1->3)-β-D-galactopyranosyl-(1->4)-D-glucose; α-L-Fuc-(1-2)-β-D-Gal-(1-3)[α-L-Fuc-(1-4)]-β-D-GlcNAc-(1-3)-β-D-Gal-(1-4)-D-Glc; O-6-Deoxy-α-L-galactopyranosyl-(1→2)-O-β-D-galactopyranosyl-(1→3)-O-[6-deoxy-α-L-galactopyranosyl-(1→4)]-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-D-glucose; Lacto-N-difucohexaose; LND 1; LND I; LNDFH-I. Grades: ≥95%. CAS No. 16789-38-1. Molecular formula: C38H65NO29. Mole weight: 999.91. | |
| Lacto-N-difucohexaose I-APD-HSA | Lacto-N-difucohexaose I-APD-HSA. | |
| Lacto-N-difucohexaose I-APD-KLH | Lacto-N-difucohexaose I-APD-KLH. | |
| Lacto-N-difucohexaose I-BSA | Lacto-N-difucohexaose I-BSA. | |
| Lacto-N-difucohexaose I-BSA (LNDFH I-BSA) (3 atom spacer) | It is a lewisb antigen linked to lactose spacer, a structure recognized by Helicobacter pylori that binds to human gastric epithelium. Alternative Names: O-6-Deoxy-α-L-galactopyranosyl-(1→2)-O-β-D-galactopyranosyl-(1→3)-O-[6-deoxy-α-L-galactopyranosyl-(1→4)]-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-D-glucose-BSA; LND I-BSA. | |
| Lacto-N-difucohexaose II | Lacto-N-difucohexaose II, a carbohydrate compound prevalent in the biomedical industry for research purposes, has been found to impede pathogen adhesion to human intestinal cells. This realization has spurred speculation on the potential of Lacto-N-difucohexaose II as a viable candidate in the development of drug interventions for infectious maladies afflicting the gut. Equally exciting, Lacto-N-difucohexaose II may also offer promise as a cancer treatment. Alternative Names: LNDFH II; Lewis A hexaose; β-D-Gal-(1-3)-[α-L-Fuc-(1-4)]-β-D-GlcNAc-(1-3)-β-D-Gal-(1-4)-[α-L-Fuc-(1-3)]-D-Glc; D-Glucose, O-6-deoxy-α-L-galactopyranosyl-(1→3)-O-[O-6-deoxy-α-L-galactopyranosyl-(1→4)-O-[β-D-galactopyranosyl-(1→3)]-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-β-D-galactopyranosyl-(1→4)]-; D-Glucose, O-α-L-fucopyranosyl-(1→4)-O-[β-D-galactopyranosyl-(1→3)]-O-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-O-[α-L-fucopyranosyl-(1→3)]-; Lacto-N-difucohexaose II; O-6-Deoxy-α-L-galactopyranosyl-(1→4)-O-[β-D-galactopyranosyl-(1→3)]-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-O-[6-deoxy-α-L-galactopyranosyl-(1→3)]-D-glucose; Lacto-N-difucopentaose II; Lacto-N-difucosylhexaose II; Lacto-N | |
| Lacto-N-difucohexaose IV | Lacto-N-difucohexaose IV, recognized as a pivotal compound constituent, presents itself as a prospective remedial aide for an array of ailments like bacterial and viral infections. By focusing on distinct receptors and impeding the proliferation of malevolent microorganisms, this indispensable compound extensively contributes to the research of pathogenic infections. Its exceptional efficacy renders it an invaluable compound for biomedical drug advancement. Alternative Names: LNDFH IV. Molecular formula: C38H65NO29. Mole weight: 999.91. | |
| Lacto-N-difucopentaose I | Lacto-N-difucopentaose I. CAS No. 221224-60-8. | |
| LACTONE OF CIS JASMONE | Cis Jasmone Lactone, a promising antitumor compound, demonstrates cytotoxicity against a range of cancer cell types, notably colon and breast cancer. Furthermore, its anti-inflammatory characteristics suggest potential applications in managing conditions like arthritis. Alternative Names: (Z)-5-Hex-3-enyldihydro-5-methylfuran-2(3H)-one, 2(3H)-Furanone, 5-(3-hexenyl)dihydro-5-methyl-, (Z)-, 2(3H)-Furanone, 5-(3Z)-3-hexenyldihydro-5-methyl-, 4-Methyl-4-hydroxy-cis-7-decenoic acid lactone, LACTONE OF CIS JASMONE. Grades: 97.0% (sum of isomers). CAS No. 70851-61-5. Molecular formula: C11H18O2. Mole weight: 182.26. | |
| Lacto-N-fucopentaose I | Lacto-N-fucopentaose I (LNFPI) is a human milk oligosaccharide (HMO), possessing antiviral and antibacterial activity. Lacto-N-fucopentaose I can reduce capsid protein VP1 to block virus adsorption, promote CDK2 and reduce cyclin E to recover cell cycle S phase block. Lacto-N-fucopentaose I inhibits ROS production and Apoptosis in virus-infected cells. Lacto-N-fucopentaose I can also regulate intestinal microbiota to affect immune system development. Alternative Names: LNFP I; Fuc-a-1,2-Gal-b-1,3-GlcNAc-b-1,3-Gal-b-1,4-Glc; Blood group O(H) type I determinant; α-l-fuc(1→2)-β-d-gal-(1→3)-β-d-glcnac-(1→3)-β-d-gal-(1→4)-d-glc; O-6-Deoxy-α-L-galactopyranosyl-(1→2)-O-β-D-galactopyranosyl-(1→3)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-D-glucose; Lacto-N-fucopentose 1; Lacto-N-fucopentose I; LNF 1; LNF I. Grades: ≥95%. CAS No. 7578-25-8. Molecular formula: C32H55NO25. Mole weight: 853.77. | |
| Lacto-N-fucopentaose I | Lacto-N-fucopentaose I (LNFPI) is a human milk oligosaccharide (HMO), possessing antiviral and antibacterial activity. Lacto-N-fucopentaose I can reduce capsid protein VP1 to block virus adsorption, promote CDK2 and reduce cyclin E to recover cell cycle S phase block. Lacto-N-fucopentaose I inhibits ROS production and apoptosis in virus-infected cells. Lacto-N-fucopentaose I can also regulate intestinal microbiota to affect immune system development[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: LNFP I. CAS No. 7578-25-8. Pack Sizes: 10 mM * 1 mL in Water; 1 mg; 5 mg; 10 mg. Product ID: HY-W019806. | |
| Lacto-N-fucopentaose I-biotin | Lacto-N-fucopentaose I-biotin is a bio-reagent in the biomedical industry. It helps researchers detect and analyze fucosylated oligosaccharides. Its biotin modification provides tactical binding options, leading to a better understanding of fucosylation events in biological processes such as pathogen binding, cancer development, and more. Alternative Names: LNFP I-biotin; O-6-Deoxy-α-L-galactopyranosyl-(1→2)-O-β-D-galactopyranosyl-(1→3)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-D-glucose-biotin. Molecular formula: C48H82N6O27S. Mole weight: 1207.26. | |
| Lacto-N-fucopentaose I-BSA | Lacto-N-fucopentaose I-BSA. | |
| Lacto-N-fucopentaose I-BSA (LNFP I-BSA) (3 atom spacer) | Lacto-N-fucopentaose I-BSA (LNFP I-BSA) (3 atom spacer) is an instrumental biomedical tool employed to unravel the intricate molecular interplay between proteins and carbohydrates. This glycoprotein conjugate harbors the enigmatic Lacto-N-fucopentaose I, a sui generis complex carbohydrate that adorns cell surfaces and resides in body fluids. The product's salience lies in its ability to diagnose and treat a plethora of ailments including cancers, infections, and inflammation. Alternative Names: O-6-Deoxy-α-L-galactopyranosyl-(1→2)-O-β-D-galactopyranosyl-(1→3)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-D-glucose-BSA; Lacto-N-fucopentose 1-BSA. | |
| Lacto-N-fucopentaose II | It is a human milk oilgosaccharide that can be associated with some gastrointestinal tumors. Alternative Names: LNFP II; Lewisa antigen; Lewis A antigen; b-D-Gal-(1→3)-(a-L-Fuc-[1→4])-b-D-GlcNAc-(1→3)-b-D-Gal-(1→4)-D-Glc; β-D-Galp-(1→3)-[α-L-Fucp-(1→4)]-β-D-GlcpNAc-(1→3)-β-D-Galp-(1→4)-D-Glcp; Lewis-a pentasaccharide; LNF II; Lacto-N-fucopentaose-2; Lea penta; O-6-Deoxy-α-L-galactopyranosyl-(1→4)-O-[β-D-galactopyranosyl-(1→3)]-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-D-glucose; Lacto-N-fucopentaose-2; Lactose-N-fucopentose II; LNF II. Grades: ≥95%. CAS No. 21973-23-9. Molecular formula: C32H55NO25. Mole weight: 853.77. | |
| Lacto-N-fucopentaose II-APD-HSA | Lacto-N-fucopentaose II-APD-HSA. | |
| Lacto-N-fucopentaose II-APD-KLH | Lacto-N-fucopentaose II-APD-KLH is an extraordinary bioactive compound prevalent in the biomedical sector, exhibiting immense promise for research across diverse diseases through its remarkable affinities for selective receptors, namely Fucosyltransferase and Galectins. It has garnered extensive utilization within research domains aiming to unravel the intricacies of cancer, inflammation and immune-related maladies, as well as devising innovative strategies for their effective research. | |
| Lacto-N-fucopentaose II-BSA | Lacto-N-fucopentaose II-BSA. | |
| Lacto-N-fucopentaose II-BSA (LNFP II-BSA) (3 atom spacer) | Lacto-N-fucopentaose II-BSA (LNFP II-BSA) (3 atom spacer), a biomedicine product designed for unravelling the mysteries of glycan-protein interactions. Widely employed for diagnosis of Helicobacter pylori (H. pylori) in serum samples of infected individuals, its applications extend beyond the laboratory. Studies have revealed its crucial role in illuminating the intricacies of carbohydrate-mediated ailments such as cancer and inflammation. Alternative Names: O-6-Deoxy-α-L-galactopyranosyl-(1→4)-O-[β-D-galactopyranosyl-(1→3)]-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-D-glucose-BSA; Lacto-N-fucopentaose-2-BSA. | |
| Lacto-N-fucopentaose II-GEL | Lacto-N-fucopentaose II-GEL is a paramount biomedical compound, serving as a tool for deciphering intricate complexities attributed to the functions and interplays of carbohydrates within cellular systems. By facilitating the detection of lectins, glycosylation analysis and exploration of carbohydrate impacts on disease advancement, this product assumes a pivotal significance. Its indispensability lies in unraveling the pathogenesis of specific ailments and forging prospects for prospective research. | |
| Lacto-N-fucopentaose III | It is a human milk oilgosaccharide that can inhibit the adherence of pathogens to the intestinal epithelium. Alternative Names: LNFP III; Lewis X antigen; Gal-b-1,4-(Fuc-a-1,3)-GlcNAc-b-1,3-D-Gal-b-1,4-Glc; Lex-lactosel; Lewis-X pentasaccharide; β-D-Galp-(1→4)-[α-L-Fucp-(1→3)]-β-D-GlcpNAc-(1→3)-β-D-Galp-(1→4)-D-Glcp; O-6-deoxy-alpha-L-galactopyranosyl-(1->3)-O-[beta-D-galactopyranosyl-(1->4)]-O-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-O-beta-D-galactopyranosyl-(1->4)-D-Glucopyranose; 6-Deoxy-α-L-galactopyranosyl-(1->3)-[β-D-galactopyranosyl-(1->4)]-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1->3)-β-D-galactopyranosyl-(1->4)-D-glucose; Lacto-N-neofucopentaose II. Grades: ≥95%. CAS No. 25541-09-7. Molecular formula: C32H55NO25. Mole weight: 853.77. | |
| Lacto-N-fucopentaose III-APD-HSA | Lacto-N-fucopentaose III-APD-HSA. | |
| Lacto-N-fucopentaose III-BSA | Lacto-N-fucopentaose III-BSA. | |
| Lacto-N-fucopentaose III-BSA (LNFP III-BSA) (3 atom spacer) | Lacto-N-fucopentaose III-BSA (LNFP III-BSA) (3 atom spacer) is an astounding specialized biomedical wonder, harbors immense value for the scientific realm. This groundbreaking product unravels the intricacies behind carbohydrate-protein interactions, facilitating a comprehensive understanding of this enigmatic domain. A conjugate brimming with potential, LNFP III-BSA amalgamates the captivating carbohydrate structure of Lacto-N-fucopentaose III with the mighty Bovine Serum Albumin (BSA) and an elegant 3 atom spacer. Its importance transcends mere investigation, offering invaluable insights into drug development and the intricate pathology of diseases intricately linked to carbohydrate recognition. Prepare to embark on an academic odyssey like no other, courtesy of LNFP III-BSA. Alternative Names: LNF-III-BSA; alpha-L-Fuc-(1->3)-[beta-D-Gal-(1->4)]-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-Glc-BSA. | |
| Lacto-N-fucopentaose III-GEL | Lacto-N-fucopentaose III-GEL is an advanced biomedical product engineered to precisely target and study diverse malignancies, including breast, ovarian and colon cancers. This exceptional gel conjugate seamlessly integrates the distinctive attributes of Lacto-N-fucopentaose III, which is a specific carbohydrate molecule, with a sophisticated gel matrix, thereby ensuring optimal drug administration and localized research. Through its selective adherence to cancerous cells, this compound holds remarkable prospects for individualized therapy, ultimately enhancing patient prognosis substantially. | |
| Lacto-N-fucopentaose V | Lacto-N-fucopentaose V, a groundbreaking biomedicine product, emerges as a pivotal therapeutic entity in the daunting battle against several diseases. Extensive scientific investigations have unraveled its potential prowess in cancer therapy by augmenting immune responses to combat malignant neoplasms. Moreover, its remarkable attributes offer hope in alleviating inflammatory bowel disease through the regulation of gut-associated inflammatory reactions. Alternative Names: LNFPV; Galb1-3GlcNAcb1-3Galb1-4(Fuca1-3)Glc; O-β-D-Galactopyranosyl-(1→3)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-O-[6-deoxy-α-L-galactopyranosyl-(1→3)]-D-glucose; Lactose-N-fucopentose 4; LNFP V; Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]aldehydo-Glc. CAS No. 60254-64-0. Molecular formula: C32H55NO25. Mole weight: 853.77. | |
| Lacto-N-fucopentaose VI | Lacto-N-fucopentaose VI is an esteemed biomedical compound, standing tall as a prodigious therapeutic ally in studying multifarious ailments. Abounding in cascading units of fucose and lactosamine, this exquisite glycan has sparked rapt attention. Careful scrutiny has unveiled its prodigious potentialities in revolutionizing the domain of cancer inhibition, inflammation mitigation and bacterial afflictions. Delving deeper into its astounding architecture and intricate workings, it emerges as a beacon of hope in the realms of targeted compound transportation and immunotherapeutic compounds. Alternative Names: LNFP VI; D-Glucose, O-β-D-galactopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-O-[6-deoxy-α-L-galactopyranosyl-(1→3)]-; Gal-b-1,4-GlcNAc-b-1,3-Gal-b-1,4-[Fuc-a1,3]Glc. Grades: 95%. CAS No. 145876-86-4. Molecular formula: C32H55NO25. Mole weight: 853.77. | |
Our database is helping our users find suppliers everyday.
